NL East

Philadelphia Phillies
PITCHER HEALTH

Preseason 2026 injury analysis, durability risk profiles, and return timelines for the Philadelphia Phillies pitching rotation.

Verified Injury Data

ROTATION OUTLOOK

Philadelphia features excellent durability with Nola but major concerns with Wheeler's shoulder surgery. Luzardo and Walker both carry significant injury risk, creating rotation depth questions.

KEY PITCHERS

Aaron Nola

RHP • #1 Starter

ANALYZE THIS PITCHER

Injury History

Remarkably durable ace. 200+ IP most seasons. Limited major injuries.

Durability Risk Profile

Nola is one of baseball's most durable aces, consistently logging 200+ innings without major injuries.

Search Keywords

Aaron Nola injury historyPhillies ace health

Zack Wheeler

RHP • #2 Starter

ANALYZE THIS PITCHER

Injury History

Blood clot in right shoulder. Venous thoracic outlet syndrome surgery (late 2025). Progressing in throwing program. Expected to miss Opening Day. Early 2026 return targeted.

Durability Risk Profile

Wheeler underwent serious shoulder surgery for blood clots and thoracic outlet syndrome in late 2025. This is a major injury that could affect velocity and effectiveness.

Search Keywords

Zack Wheeler injury update 2026Wheeler shoulder surgery

Ranger Suárez

LHP • #3 Starter

ANALYZE THIS PITCHER

Injury History

Generally healthy. Back-to-back strong seasons. Limited injury history.

Durability Risk Profile

Suárez has been durable with back-to-back healthy, productive seasons.

Search Keywords

Ranger Suarez injury historyPhillies Suarez health

Jesus Luzardo

LHP • #4 Starter

ANALYZE THIS PITCHER

Injury History

Acquired from Marlins (December 2024). Injury history includes elbow issues. Moderate durability concerns.

Durability Risk Profile

Luzardo was traded to Philadelphia with a history of elbow injuries and IL stints.

Search Keywords

Jesus Luzardo injury historyPhillies Luzardo trade

PROTECT YOUR PITCHERS

Upload pitching video and get instant biomechanical injury risk analysis powered by AI.